Search by Drug Name or NDC
NDC 00003-0893-91 ELIQUIS 2.5 mg/1 Details
ELIQUIS 2.5 mg/1
ELIQUIS is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by E.R. Squibb & Sons, L.L.C.. The primary component is APIXABAN.
MedlinePlus Drug Summary
Apixaban is used help prevent strokes or blood clots in people who have atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body and possibly causing strokes) that is not caused by heart valve disease. Apixaban is also used to prevent deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in people who are having hip replacement or knee replacement surgery. Apixaban is also used to treat DVT and PE and may be continued to prevent DVT and PE from happening again after the initial treatment is completed. Apixaban is in a class of medications called factor Xa inhibitors. It works by blocking the action of a certain natural substance that helps blood clots to form.
Related Packages: 00003-0893-91Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Apixaban
Product Information
| NDC | 00003-0893 |
|---|---|
| Product ID | 0003-0893_a260aeff-75b6-4468-bc8a-c2f8d6ac66e3 |
| Associated GPIs | 83370010000320 |
| GCN Sequence Number | 067642 |
| GCN Sequence Number Description | apixaban TABLET 2.5 MG ORAL |
| HIC3 | M9V |
| HIC3 Description | DIRECT FACTOR XA INHIBITORS |
| GCN | 30239 |
| HICL Sequence Number | 037792 |
| HICL Sequence Number Description | APIXABAN |
| Brand/Generic | Brand |
| Proprietary Name | ELIQUIS |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | apixaban |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | APIXABAN |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Pharmaceutical Class | Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA202155 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00003-0893-91 (00003089391)
| NDC Package Code | 0003-0893-91 |
|---|---|
| Billing NDC | 00003089391 |
| Package | 1 BLISTER PACK in 1 CARTON (0003-0893-91) / 14 TABLET, FILM COATED in 1 BLISTER PACK |
| Marketing Start Date | 2012-12-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |